NEWS
AMBOSS ACQUIRES NOVAHEAL TO STRENGTHEN ITS POSITION IN THE GERMAN NURSING MARKET AND AS A HUB FOR HEALTHCARE TALENT AND KNOWLEDGE
AMBOSS , the leading medical knowledge and learning platform in Germany , has announced its acquisition of Novaheal , a pioneering EdTech start-up that developed an innovative platform for nursing education . This acquisition positions AMBOSS as a comprehensive digital partner for the two largest healthcare professions – physicians and nurses – providing them with professional tools for education , training , and daily practice .
The acquisition aligns with AMBOSS ’ s vision of empowering healthcare professionals from the beginning of their careers , offering continuous support through digital knowledge solutions tailored to their unique needs . With more than
1.7 million healthcare professionals working in nursing in Germany alone , AMBOSS is making significant strides toward addressing the global workforce shortage in healthcare by streamlining and enhancing interprofessional collaboration .
“ Joining forces with AMBOSS creates powerful synergies between nursing and medical education ,” said Samuel Bongartz , Co-founder and CSO of Novaheal . “ We are now better equipped to deliver comprehensive resources that address the unique challenges faced by healthcare workers . Our combined expertise and shared vision will allow us to continue innovating in healthcare education , ensuring professionals have access to the tools they need , wherever they are in their careers .”
Dr Sievert Weiss ( Co-founder und Medical Director von AMBOSS ), Turan Tahmas ( Cofounder und CEO von Novaheal ), Samuel Bongartz ( Co-founder und CSO von Novaheal ), Valentin Johannsen ( Co-Founder und CPO von Novaheal ) / Copyright : AMBOSS
NEW TRIAL FOR PROSTATE CANCER SCREENING IN THE HOME
Dr Rav Sodi , Consultant Clinical Biochemist for Mid and South Essex NHS Foundation Trust , has partnered with Yorkshire- and Edinburgh-based MedTech company TestCard and global diagnostics manufacturer Healgen to deliver a trial of prostate cancer screening in the home . This disruptive innovation allows patients to screen for prostate cancer in the comfort , convenience and privacy of their own homes supported by the Mid and South Essex NHS Foundation Trust .
The trial will see patients receive a TestCard test kit through the post , which contains the Healgen semi-quantitative PSA lateral flow test and be invited to download a mobile app to help them perform the test . The test results and images will be sent directly to a clinician who will decide on the next steps . The test requires only a finger prick blood sample and can be completed in 10 minutes .
Historically , prostate cancer screening has required patients to travel to a clinic for a blood test and then travel again to receive their results . These friction points during screening can cause patients to put off their appointments or not to attend at all .
Prostate cancer is treatable when caught early – the disease has a five-year survival rate of more than 98 % when caught at Stage 1 . However , if prostate cancer is not caught until Stage 4 , the disease has a 5-year survival rate of as low as 28 %.
Early screening is the key to lowering rates of fatality caused by prostate cancer , a disease that at least one in eight men in the UK will experience in their lifetimes . Traditional screening methods engender barriers like travel time , time off work , paid parking , care commitments and personal embarrassment . Screening in the home can empower patients to take control of their own healthcare , freeing up clinics and clinicians to concentrate on the patients who need care the most .
Dr Rav Sodi commented : “ I am excited to introduce a new way to screen patients for prostate cancer , in the home . I believe we will catch more prostate cancer cases early by making it easier for patients to screen ; therefore , we may be able to save more lives . Our partnership with TestCard allows us to provide this service into the home and still allow clinicians to review the results and provide counsel to their patients .”
10 www . intelligenthealth . tech